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Entry into host macrophages and evasion of intra-
cellular destruction mechanisms, including phago-
some-lysosome fusion, are critical elements of
Mycobacterium tuberculosis (Mtb) pathogenesis.
To achieve this, the Mtb genome encodes several
proteins that modify host signaling pathways. PtpA,
a low-molecular weight tyrosine phosphatase, is a
secreted Mtb protein of unknown function. The lack
of tyrosine kinases in the Mtb genome suggests
that PtpA may modulate host tyrosine phosphory-
lated protein(s). We report that a genetic deletion of
ptpA attenuatesMtb growth in humanmacrophages,
and expression of PtpA-neutralizing antibodies
simulated this effect.We identify VPS33B, a regulator
of membrane fusion, as a PtpA substrate. VPS33B
and PtpA colocalize in Mtb-infected human macro-
phages. PtpA secretion combined with active-phos-
phorylated VPS33B inhibited phagosome-lysosome
fusion, a process arrested in Mtb infections. These
results demonstrate that PtpA is essential for Mtb
intracellular persistence and identify a key host
regulatory pathway that is inactivated by Mtb.
INTRODUCTION
Tuberculosis (TB), caused by the facultative intracellular patho-
gen Mycobacterium tuberculosis, remains a leading cause of
death due to infectious disease in the world today and poses
a serious challenge to international public health. Ten million
new cases of TB arise annually, causing about 2 million deaths
each year (Raviglione, 2003).
Entry into host macrophages and evasion of intracellular de-
struction mechanisms are pivotal to M. tuberculosis virulence.
Crosstalk between host macrophages and the infecting bacteria
is essential for bacterial survival in vivo. Host signaling proteins
are modified by mycobacterial infection (Hestvik et al., 2003),
and M. tuberculosis secretes proteins that contributes to the
inhibition of phagosome maturation. For instance, an M. tuber-
culosis lipid phosphatase, SapM, acts by hydrolyzing the host
phosphatidylinositol-3- phosphate (PI3P) (Vergne et al., 2005).
Pathogenic bacteria are reported to secrete low-molecular
weight tyrosine phosphatases during infection (Bach et al.,316 Cell Host & Microbe 3, 316–322, May 2008 ª2008 Elsevier Inc.2006; Bliska et al., 1992; Fu and Galan, 1998). M. tuberculosis
PtpA is such a low-molecular weight tyrosine phosphatase (Cow-
ley et al., 2002). The lack of annotated tyrosine kinase genes in
the M. tuberculosis genome sequence database (Cole et al.,
1998) suggests that PtpA may mediate host-pathogen interac-
tions during infection. Here, we report that VPS33B, a host pro-
tein involved in vesicle trafficking, is dephosphorylated by PtpA
leading to a block of phagosome maturation byM. tuberculosis.
RESULTS
Growth of M. tuberculosis DptpA Mutant Is Attenuated
in Human Macrophages
To assess the contribution of PtpA to M. tuberculosis virulence
and infectivity, we created a ptpA knockout strain ofM. tubercu-
losis by allelic exchange (Papavinasasundaram et al., 2005)
(Figure 1A and Figure S1 available online). Compared to its
parental strain, H37Rv, theDptpAmutant showed no differences
in its in vitro growth characteristics both in rolling aerobic or
semistatic cultures (Figure 1B). However, competitive coinfec-
tion of THP-1 macrophages with DptpA and its parental strain
demonstrated that ptpA is required for successful long-term
infection (Figure 1C). Although the wild-type and DptpA mutant
showed similar infectivity with similar colony forming units
(CFU) obtained 2 hr postinfection, the DptpA mutant showed
a reduction of more than two logs in intracellular survival over
48 hr (Figure 1C). During independent infection of macrophages
(Figure 1D), the mutant strain was rapidly cleared; after 72 hr, live
bacteria CFUs were reduced by a magnitude of three logs. In
contrast, the parental strain and the complemented DptpA
mutant established stable infections after 24 hr. The growth of
complemented mutants expressing inactive PtpA was also
attenuated but to a lesser degree compared to the DptpA strain.
Survival of M. tuberculosis Is Attenuated
in Macrophages Expressing aPtpA
Single-Chain Antibodies
To identify the location in which PtpA functions, we used the sin-
gle-chain antibody, sc-007, directed against PtpA (Kd=0.92mM).
Incubation with sc-007 reduced the catalytic activity of PtpA by
60% as monitored by p-nitrophenyl phosphate cleavage (data
not shown). Thereafter, the gene encoding sc-007 was trans-
fected and stably expressed to produce intracellular antibodies
(intrabodies) inmacrophages; theyieldwas150ng intrabodies/106
cells (Figure S2). Expression of sc-007 in the macrophage
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fection. Reduced survival was not observed in cells expressing
antibodies against an unrelated protein (anti-bovine ubiquitin)
(Figure 1E). As expected, the growth of DptpA in the presence
of sc-007 was similar to the parental strain. M. tuberculosis
growth attenuation provided further evidence that PtpA is
required for mycobacterial growth in vivo. The reduction of
M. tuberculosis survival by inactivating PtpA in the macrophage
cytosol outside the mycobacterial phagosome strengthens our
hypothesis that PtpA functions within host cells.
Figure 1. M. tuberculosis DptpA Construction and Analyses
(A) (I) Map showing the ptpA genomic region and modification introduced
during the mutant construction. (II) Southern hybridization using a-32P-radio-
actively labeled probe hybridized to a 4.5 kb XhoI fragment for H37Rv wild-
type (1) and a 2.1 kb fragment for the DptpA mutant (2) as predicted based
on restriction map analysis.
(B) In vitro growth of H37Rv wild-type and the DptpA mutant strain. The wild-
type and DptpA mutant strain displayed similar growth rate in 7H9 liquid
medium when incubated as rolling cultures. Similar results were observed
for wild-type and the mutant in static cultures. In static growth, shown are
the mean values (±SD) of three independent experiments.
(C) Competitive coinfection of DptpA mutant and its parental strain. Macro-
phages were infected with an opsonized mixture (1:1) of wild-type and mutant
strains at an moi of 1:10 for 2 hr and placed at 37C and 5%CO2 after washing
away noninternalized bacteria. Macrophages were processed according to
Supplemental Experimental Procedures. Shown are the mean values (±SD)
of three independent experiments.
(D) M. tuberculosis survival in infected macrophages. DptpA+pptpA repre-
sents the mutant complemented with ptpA. Infected macrophages were
processed as described in the Experimental Procedures. Shown are the
mean values (±SD) of three independent experiments.
(E) M. tuberculosis survival in stable-transfected macrophages expressing
intrabodies against PtpA. Stable-transfected macrophages were obtained
as described in the Experimental Procedures. Shown are the mean values
(±SD) of three independent experiments.Host VPS33B Is a PtpA Substrate
To identify host proteins that interact with PtpA, we used a ‘‘sub-
strate trapping’’ assay, based on methodology used to identify
substrates for the Y. pseudotuberculosis phosphatase YopH in
HeLa cells (Bliska et al., 1992). This mechanism-based approach
utilizes a catalytically defective mutant of PtpA to trap substrate
complexes. PTPs contain a cysteine nucleophile (Cys11 within
the highly conserved sequence C-X5-R) that forms a phospho-
cysteinyl intermediate during catalysis (Barford et al., 1998)
and a conserved aspartate residue (Asp126) that acts as a gen-
eral acid/base to protonate the tyrosine phenolic leaving group
(Madhurantakam et al., 2005) (Supplemental Data). We hypoth-
esized that mutation of the PtpA catalytic aspartic acid to an al-
anine (Asp126Ala) would result in a catalytically defective PtpA
that, like other similar PTP family mutants, would ‘‘trap’’ host
substrate proteins by stabilizing the covalent enzyme-substrate
complexes. To test this approach, we constructed and overex-
pressed the Asp126Ala, Cys11Ala, and Arg17Ala (Supplemental
Data and Figure S3A) mutants as well as wild-type PtpA. As ex-
pected, only the wild-type PtpA retained phosphatase activity
(Figure S3B). After the addition of the Asp126Ala-PtpA protein
to a THP-1macrophage lysate, a proteinmigrating at amolecular
weight of about 70 kDa was trapped (Figure 2AI, lane 4). MALDI-
TOF mass spectrometry identified this protein as hVPS33B
(human Vacuolar Protein Sorting 33B). Western analysis of the
trapped proteins confirmed the identification of VPS33B as the
binding partner of Asp126Ala-PtpA (Figure 2AIIb).
PtpA Directly Binds to and Dephosphorylates VPS33B
To ascertain if VPS33B serves as a tyrosine phosphorylated
substrate of PtpA, we overexpressed, purified, and checked
the phosphorylation properties of VPS33B. We found that
VPS33B is a self-phosphorylating kinase. Autophosphorylation
of VPS33B occurred at tyrosine residues, as revealed by
the extent of g32P-ATP incorporation in an in vitro kinase assay
followed by phospho-amino acid analysis (Figure 2B). Moreover,
site-directed mutagenesis of selected tyrosine residues in
VPS33B significantly reduced autophosphorylation activity
(Figure S7 and Figure 2E).
To demonstrate the interaction of PtpA and VPS33B in vitro,
we used three separate approaches: a biochemical assay, pro-
tein-protein interaction analysis, and coimmunoprecipitation.
The biochemical assay revealed that the extent of g32P-ATP
incorporation into VPS33B was significantly reduced when
recombinant active PtpA was included in the reaction mix
(Figure 2C). Furthermore, dephosphorylation of VPS33B by
active PtpA was dose- and time-dependent, while the catalytic-
defective mutants Cys11Ala, Arg17Ala, and Asp126Ala failed to
dephosphorylate VPS33B, confirming that the catalytic site is
essential for the enzymatic activity of PtpA (Figure S5). The direct
interaction of PtpA with VPS33B was confirmed using the ampli-
fied luminescent proximity assay. The activity of low-molecular
weight phosphatases have been reported to be redox sensitive
(Caselli et al., 1998), and two cysteines (C11 and C16) in the ac-
tive site of PtpA protect the catalytic site serving as a ‘‘self-lock’’
when the redox status changes. The Cys11Ala mutant, which
does not form the locked S-S bridge, was used to test the bind-
ing of PtpA to VPS33B. As shown in Figure S6, Cys11Ala PtpA
bound to VPS33B with Kd of 2.1 nM.Cell Host & Microbe 3, 316–322, May 2008 ª2008 Elsevier Inc. 317
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(A) (I) Substrate trapping using phosphatase-active and -defective PtpA. The
spot in lane 4 marked with a white dashed ellipse corresponds to VPS33B.
The proteins in lanes 2 and 3 are not dephosphorylated by active PtpA. (II)
Western blotting of trapping gel showing VPS33B bound to PtpA. (a) Mem-
brane exposed to rabbit aPtpA antibodies. (b) Same membrane exposed to
sheep aVPS33B after stripping.
(B) VPS33B is autophosphorylated on tyrosine residues as determined by
acidic hydrolysis and separation on TLC. Retention factor: serine (S), 0.40;
threonine (T), 0.48; tyrosine (Y) 0.53; VPS33B, 0.51.
(C) Radiolabeling analysis of in vitro dephosphorylation of autophosphorylated
recombinant VPS33B by active PtpA (upper image). In VPS33B+PtpA, 0.3 mg
of active PtpA was added. Equal loading of VPS33B (lower image) was
revealed by silver staining.
(D) (I) Immunoprecipitation of VPS33B by Asp126Ala-PtpA from macrophages
lysate. Lysate was coimmunoprecipitated with aPtpA antibodies, resolved on
SDS-PAGE, and blotted onto a nitrocellulose membrane. A band matching
VPS33Bwas observed after incubation of themembrane with sheep aVPS33B
and donkey asheep antibodies. (II) Control blot. The same membrane was in-
cubated with rabbit aPtpA and goat arabbit antibodies after protein stripping.
Black arrow indicates VPS33B. The difference in the pattern migration might
be due to mammalian posttranslational in THP-1 cells versus E.coli which is
the host for recombinant VPS33B.
(E) Autophosphorylation activity of site-directed mutated tyrosine residues in
VPS33B. Autophosphorylation rates of site-directed mutated VPS33Bs were
tested in an in vitro kinase assay. Samples were resolved in a 10% SDS gel
and exposed to a screen for radiolabeled band localization. After gel drying,
the band corresponding to the phosphorylated spots was excised from the
gel, and the radioactive incorporation was measured in a scintillation counter.
Images represent the radioactivity of the dried gel. Double is defined as the
site-directed mutagenesis of Y133E and Y382E, triple includes the same mu-
tated residues as the double mutant + Y511E, while the quadruple includes the
samemutated residues as the triplemutant + Y517E. Results are expressed as
mean ± SD.318 Cell Host & Microbe 3, 316–322, May 2008 ª2008 Elsevier Inc.The interaction of PtpA and VPS33Bwas further demonstrated
in a separate ex vivo experiment. We pulled down VPS33B from
a THP-1 lysate using the PtpA Asp126Ala mutant. The complex
was immunoprecipitated from the lysate using antibodies
against PtpA. Exposure of the immunoblot to aVPS33B anti-
bodies showed a band matching the size of the substrate (Fig-
ure 2DI). Taken together, these findings confirm that human
VPS33B is a genuine substrate for mycobacterial PtpA.
PtpA and VPS33BColocalize inM. tuberculosis-Infected
Macrophages
If VPS33B is an in vivo substrate of PtpA, then these two proteins
should colocalize in M. tuberculosis-infected macrophages. To
test this prediction, we used antibodies directed against PtpA
and VPS33B to stain THP-1-derived macrophages infected
with live or killed M. tuberculosis (Figure 3A). In these experi-
ments, VPS33B and PtpA staining overlapped in the periphery
of phagosomes. As expected in the case of a secreted protein,
PtpA was detected only in phagosomes containing live, but not
killed, bacilli (Figure 3A).Macrophages infectedwithDptpAM. tu-
berculosis did not show colocalization of PtpA and VPS33B,
demonstrating the specificity of the aPtpA antibodies (Figure 3A).
Colocalization analyses (Supplemental Data) were statistically
relevant with a Mander’s overlap coefficient (R) of 0.971 for live
bacteria (0.087 for killed) and Pearson’s correlation coefficient
(Rr) of 0.924 (0.045 for killed); see Supplemental Data for details.
PtpA and VPS33B colocalization was confirmed by electron
microscopy. Immunogold labeling of macrophages infected
with M. tuberculosis H37Rv clearly showed that PtpA closely
associated with VPS33B in the macrophage (Figure 3B). An im-
munoblot analysis of the cytosol/membrane fractionation was
performed (Figure 3C). The cytosolic fraction of M. tuberculo-
sis-infected macrophages (Figure 3C) show limited visibility of
PtpA in macrophage cytosol. However, a band corresponding
to PtpA is present in the cytosolic fraction of macrophages in-
fected with a strain expressing PtpA from an extrachromosomal
plasmid. These experiments confirmed that (1) PtpA is secreted
outside of the mycobacterial phagosome and (2) PtpA and
VPS33B colocalize in the macrophage cytosol.
In yeast, the membrane-associated proteins VPS11, VPS16,
VPS18, and VPS33 form a protein complex termed Class C.
This complex has been shown to be involved in SNARE-
mediated membrane fusion (Rieder and Emr, 1997). VPS33B is
recruited from the cytosol and interacts with membrane-associ-
ated Class C subunits (specifically VPS16) to allow the complex
to migrate to the vacuole (Rieder and Emr, 1997). Analysis of
M. tuberculosis-infected macrophages labeled with antibodies
against VPS16 and PtpA clearly demonstrate colocalization of
PtpA and VPS16 (Figure 3D).
Overall, these studies support the evidence that VPS33B inter-
acts specifically with secreted PtpA in vivo and are in accor-
dance with the identification of VPS33B as a specific substrate
PtpA. Furthermore they suggest that mycobacterial PtpA func-
tions with the Class C complex to influence processes in the
phagosome of infected macrophages.
PtpA Inhibits Phagosome-Lysosome Fusion
One of the key mechanisms by which mycobacteria avoid the
microbicidal activity of macrophages is the inhibition of fusion
Cell Host & Microbe
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tigate the role of PtpA in blocking phagosome maturation, mac-
rophages were exposed to latex beads non-covalently coated
with PtpA, bovine serum albumin (BSA) or one of two phospha-
tase-defective mutants Cys11Ala, and Asp126Ala. After inges-
tion of coated beads, phagosome maturation was examined by
Figure 3. Colocalization of PtpA VPS33B and VPS16 in Infected
Macrophages
(A) Macrophages were infected with live or killed bacteria and then processed
and immunostained as described in the Supplemental Data. Goat-arabbit cou-
pled to Alexa 488 was used as to detect aPtpA, while donkey-asheep coupled
to Alexa 633 was used against aVPS33B. Bacteria were stained with Alexa
555. White bar is 20 mm.
(B) Electron microscopy of M. tuberculosis H37Rv-infected macrophages.
Magnification, 97003; inserts, 970003. Bar in the insert is 0.2 mm. VPS33B
and PtpA were localized in the macrophage cytosol using 10 nm gold-labeled
PtpA (white arrows) and 18 nm gold-labeled VPS33B (arrowheads). The
bottom insert shows an independent experiment.
(C) Western analysis of PtpA presence in cytosolic (C) or membrane
(M) compartments of infected macrophages. Lanes 1 (C) and 2 (M) WT-
infected macrophages; lanes 3 (C) and 4 (M) DptpA-infected macrophages;
and lanes 5 (C) and 6 (M) DptpA+pptpA-infected macrophages.
(D) Colocalization of VPS16 and PtpA. Macrophages were infected with the
wild-type strain and processed as described in the Supplemental Data.
Goat-arabbit coupled to Alexa 488 was used as to detect aPtpA, while don-
key-asheep coupled to Alexa 633 was used against a VPS16. Bar is 20 mm.flow cytometry (FACS) (Hmama et al., 2004). The ability of PtpA
to translocate into the cytosol by crossing the phagosomemem-
branewasdemonstratedbyWesternblotting of cytosolic fraction
from macrophages ingesting PtpA-coated beads. Moreover,
electron microscopy clearly showed that PtpA was detached
from the latex beads and crossed the phagosomal membrane
toward the cytosol (Figures S8 and S9). There was a 60%
reduction in phagolysosomal fusion in macrophages containing
PtpA-coated beads (Figure 4A, WT; Figure S10) compared to
phagosomes containing BSA-coated beads. In contrast, mu-
tated forms of PtpA had a marginal effect on phagolysosome
fusion. Furthermore, beads coated with active PtpA and incu-
bated with sc-007 antibody lost their ability to inhibit phagolyso-
some fusion (Figure 4A, WT-007). These results were further
confirmed by fluorescence (Figure 4B) and electron microscopy
(Figure S8) of the PtpA-coated latex beads. These analyses re-
vealed recruitment of VPS33B to the phagosome, but not a
complete colocalization to the lysosome,while BSA-coated latex
beads recruited VPS33B, which allows them to migrate toward
lysosomes (Figure 4B). These data suggest that M. tuberculosis
PtpA inhibits phagosome maturation.
Influence of PtpA in Phagolysosome Fusion in Presence
or Absence of VPS33B
To assess the role of VPS33B in phagosome maturation, we
attenuated the expression of endogenous VPS33B expression
in THP-1 cells using a siRNA-based approach.Macrophages ex-
pressing two independent siRNA against VPS33B sequences
showed a significant reduction in their ability to mediate phago-
some-lysosome fusion, indicating that VPS33B is essential for
this process (Figure S11). No effect was observed in the pattern
of phagosome-lysosome fusion when the control scramble
RNA was used (Figure S11). Furthermore, macrophages with
silenced VPS33B expression failed to distinguish between PtpA-,
Arg17Ala-, or BSA-coated latex beads in a phagosome matura-
tion assay (Figure S11), whereas complementing VPS33B-
silenced cells by providing active recombinant WT-VPS33B
restored the inhibition of phagolysosome fusion only by PtpA-
coated beads (Figure 4C and Figure S12). In contrast, equivalent
amounts of quadruple-tyrosine-mutated VPS33B (Figure 2E)
delivered to the silenced macrophages did not restore the inhibi-
tion of phagolysosome fusion by PtpA-coated beads (Figures 4C
andFigure S12). Together, these results demonstrate a direct role
for phosphorylated VPS33B in PtpA-dependent phagolysosome
fusion.
DISCUSSION
Interference with host signaling is a common theme in bacterial
pathogenesis. For example, the Salmonella and Yersinia phos-
phatases, SptP (Fu and Galan, 1998) and YopH (Bliska et al.,
1992), are secreted into host cells where they interact with
several adhesion proteins. Here, we provide evidence that M.
tuberculosis utilizes a similar strategy in that it secretes the pro-
tein phosphatase PtpA to promote its survival within the host.
The M. tuberculosis DptpA strain was severely attenuated
when invading macrophages but showed no reduction in growth
rate compared to the wild-type in axenic culture. A similar reduc-
tion in survival was observed when macrophages expressingCell Host & Microbe 3, 316–322, May 2008 ª2008 Elsevier Inc. 319
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were infected with WT M. tuberculosis. Together, these results
demonstrate that PtpA is required to establish stable infections
in macrophages.
Although it has been shown that PtpA is secreted in different
mycobacterial strains both in vitro (Koul et al., 2000) and in
Figure 4. Contribution of PtpA and VPS33B to Inhibition of
Phagolysosome Fusion
Inhibition of phagolysosome fusion by latex beads coated with either active
PtpA or phosphatase-defective PtpA mutants. Phagolysosome fusion was
quantified using FACS on the basis of colocalization of fluorescent FITC-dex-
tran loaded lysosomes and coated beads containing phagosomes.
(A) Percentage of phagosome fusion to lysosome relative to fusion of phago-
somes containing BSA-coated beads. WT-007 represents active PtpA
exposed to the sc007 prior to bead protein coating. C11A and D126A are
catalytic-defective mutants of PtpA. Asterisk represents a statistical mean
difference using ANOVA one-way analysis. p value = 0.0073. Shown are the
mean values (±SD) of three independent experiments.
(B) Colocalization of active PtpA- (WT) or BSA-coated beads and VPS33B in
infected macrophages was investigated using confocal microscopy. Donkey
asheep coupled to Alexa 633 was used as secondary antibody. Bar is 20 mm.
(C) Macrophages depleted of endogenous VPS33B by siRNA (sequence no.
J-7261-09)were complementedby delivering exogenousWTor quadruple tyro-
sine mutant VPS33B using a Profect delivering reagent (Supplemental Data).
Complemented macrophages were labeled with FITC-dextran and infected,
quantified, and presented as described above. Asterisk represents a statistical
mean difference using ANOVA one-way analysis. p value = 0.0001. Shown are
themean values (±SD) of three independent experiments. Geometricalmean is
the distribution parameter given by the FACSmachine and is obtained by mul-
tiplying the ‘‘n’’ individual values of a cluster together and getting the nth root of
this product.320 Cell Host & Microbe 3, 316–322, May 2008 ª2008 Elsevier Inc.vivo (Bach et al., 2006), transit of PtpA into the host cytosol
requires passage through the host phagosome membrane. We
have clearly demonstrated that PtpA is able to overcome this
barrier, as it is present in the macrophage cytosol where it in-
teracts with the host cytosolic protein VPS33B. One report
suggests that mycobacterial proteins whose subunit size does
not exceed 70 kDa are able to cross the phagosomal membrane
(Teitelbaum et al., 1999); as PtpA is 18 kDa, this supports our
data.
Usually, microorganisms engulfed by phagocytes are translo-
cated from phagosomes to lysosomes in a process termed
phago-lysosome fusion. This is a tightly regulated process
involving membrane budding, targeting of vesicles with specific
markers, and fusion of distinct compartments of the endocytic
pathway. As macrophages infected with WT-PtpA-coated
beads caused a pronounced inhibition of phago-lysosome
fusion, we conclude that PtpA interferes with this process. This
theory is supported by the identification of VPS33B as the host
substrate of PtpA. VPS33B is a member of the Class C complex
(Banta et al., 1988) ubiquitously expressed in eukaryotic cells
and is essential for vesicle trafficking (Huizing et al., 2001). Muta-
tions in this protein cause ARC syndrome, a human genetic
disorder causing impaired kidney and liver function followed by
early death (Gissen et al., 2004), and the carnation eye-color
mutant inDrosophila (Sevrioukov et al., 1999). The yeast ortholog
of VPS33B, Vps33p, is an ATP-binding protein (Gerhardt et al.,
1998) required for vacuole morphogenesis and linked to traffick-
ing of proteins from the Golgi to vacuoles (Banta et al., 1990).
We demonstrated that PtpA colocalizes in vivo with VPS33B
when macrophages were infected with live, but not killed bacte-
ria, underlining the need for active secretion (Figure 3A). Electron
microscopic analyses of immunolabeled proteins clearly show
colocalization of PtpA with VPS33B in the host cytosol (Fig-
ure 3B). Furthermore, we demonstrated colocalization of PtpA
with VPS16 (Figure 3D), a protein which has been shown to inter-
act with the VPS33B homolog in yeast (Rieder and Emr, 1997).
These results suggest that PtpA is recruited to the Class C
complex of proteins and interferes directly with vesicular traffick-
ing in the infected macrophage.
Macrophages infected with WT-PtpA-coated beads were
impaired in their ability to initiate phagolysosomal fusion in com-
parison with those given beads coated with BSA or catalytic-
defective PtpA. However, siRNA-mediated silencing of VPS33B
rendered macrophages incapable of differentiating between the
two, although both were phagocytosed with equal efficiency
(Figure S11). The loss of VSP33B impairs this process. As
expected, when recombinant WT-VPS33B was exogenously
delivered into silenced macrophages, WT-PtpA-coated beads
regained their ability to arrest phago-lysosome fusion. These
findings demonstrate that VPS33B is required for phagosome
delivery to the lysosome. To validate these observations, we
exchanged predicted phosphorylable tyrosine residues with glu-
tamate by site-directed mutagenesis. As substitution of tyrosine
for glutamate mimics constitutive phosphorylation, we expected
that this quadruple mutant of VPS33B would be constitutively
active, as well as resistant to PtpA activity. Indeed, VPS33B-
silenced macrophages complemented with mutant VPS33B
showed exacerbated phago-lysosome fusion compared to
macrophages expressing WT-VPS33B when infected with
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cated scenario in which the constitutively active mutant
VSP33B is rendered resistant to PtpA activity and the resulting
impairment of phagolysosomal fusion. Together, these results
provide strong evidence that PtpA impairs phagolysosomal
fusion in Mtb-infected macrophages by desphosphorylation of
VPS33B.
To our knowledge, PtpA is the first M. tuberculosis enzyme
shown to interact directly with an identified host protein sub-
strate. This interaction provides evidence of an M. tuberculosis
protein disrupting macrophage signaling. PtpA joins two other
M. tuberculosis proteins that have been linked to phagosome
maturation arrest, including a protein kinase, PknG (Cowley
et al., 2004; Walburger et al., 2004), with a yet unidentified
substrate, and the lipid phosphatase SapM (Vergne et al.,
2005). Together, these results imply that M. tuberculosis uses




M. tuberculosis strain H37Rv was grown in 7H9 medium supplemented with
0.05% Tween-80 (Fisher) (7H9T) and 10% OADC (Becton Dickinson).
M. smegmatis mc2155 was utilized for protein overexpression and cultured
in 7H9T medium supplemented with 1% glucose and 50 mg/ml hygromycin
(Calbiochem). THP-1 cells were grown in RPMI 1640 (Sigma) supplemented
with 1% L-glutamine, 10 mM HEPES, 100 mg/ml Streptomycin, 100 U/ml
Penicillin (Stem Cell Technologies), 0.1% Fungizone (Invitrogen), and 10%
fetal calf serum (FCS) (Sigma). Cells were incubated at 37C supplemented
with 5% CO2. Polyclonal antibodies against VPS33B were kindly provided by
Dr. C. MacKintosh (Protein Phosphorylation Unit, University of Dundee, UK).
Polyclonal antibodies against PtpA were used according to published protocols
(Cowley et al., 2002), and secondary antibodies were obtained commercially.
Construction and Isolation of M. tuberculosis ptpA Deletion Mutant
The ptpA deletion mutant was constructed by allelic replacement and was
isolated by a sequential two-step selection protocol as described earlier
(Papavinasasundaram et al., 2005).
Mass Spectrometry Analyses
Resolved proteins were digested and bands from SDS-PAGE were analyzed
by MALDI-TOF (Voyager-DE STR work station, Laboratory of Molecular
Biophysics, University of British Columbia, Canada).
Substrate Trapping and SDS-PAGE
Substrate trapping was carried out by incubation of a THP-1 lysate with either
recombinant wild-type PtpA, Cys11Ala, or Asp126Ala mutants at 4C over-
night. The mixture was purified using Ni-NTA resin (QIAGEN) and resolved in
SDS-PAGE.
Immunoprecipitation of Immunocomplexes
Recombinant Asp126Ala-PtpA was incubated overnight with a THP-1 lysate
at 4C and then incubated a further 2 hr with aPtpA polyclonal antibodies.
The immunocomplexes were purified (Prosep-G, Millipore), resolved by 10%
SDS-PAGE, and immunoblotted onto a nitrocellulose membrane. The mem-
brane was blocked with 3% BSA/PBS, incubated with aVPS33B polyclonal
antibodies followed by incubation with secondary antibodies, and developed
using chemiluminescence (Pierce).
Immunofluorescence Microscopy
Bacteria were prepared and labeled with Alexa 555 (Invitrogen) as described
elsewhere (Bach et al., 2006). Macrophages were infected with bacteria at
a multiplicity of infection (moi) of 1:10, fixed with 2.5% p-formaldehyde, and
permeabilized with saponin (Bach et al., 2006). Confocal images were takenwith a Zeiss Confocal Microscope model LSM510 Meta (Bioimaging Facility,
University of British Columbia, BC, Canada). Images were collected using
the filters required for excitation of the respective secondary antibodies (488
and 633 nm) as well as for bacterium visualization (561 nm). Confocal images
were processed with the ImageJ program.
Single-Chain Antibodies
Tomlinson I+J single-chain Fv antibody (scFv) libraries were kindly supplied by
Geneservice, Cambridge, UK. Recombinant active PtpA was utilized as anti-
gen for screening. Selected genes coding for scFv-aPtpA were amplified by
PCR using oligonucleotides designed with XbaI (forward) and HindIII (reverse)
restriction sites. The amplified genes were subsequently cloned into pMAL-2X
(NEB, MA), and amplified again as fused genes tomalE (Bach et al., 2001) con-
taining NheI (forward) and HindIII (reverse) restriction sites. malE fused to the
scFv genes were cloned into pDSRed2-N1 (Clontech). scFv-abovine ubiquitin
was provided by Geneservice, Cambridge, UK.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures, 15
supplemental figures, and one supplemental table and can be found with
this article online at http://www.cellhostandmicrobe.com/cgi/content/full/3/
5/316/DC1/.
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